Enabling glycan biomarker detection & analysis

Glycosensors and Diagnostics, LLC (G&D) is commercializing enabling technologies for applications in glycoscience. G&D’s Lectenz® reagents are engineered with high affinity and specificity for glycan structures of interest. G&D is also translating its Lectenz® technology into an easy-to-use application platform called GlycoSense™ for glycan detection and analysis in applications such as disease biomarker detection and bioprocessing of biologics and biosimilars.

News

Visit G&D exhibit at BIO 2015 in Philidephia as part of the State of Georgia's Pavilion.

G&D's CSO, Dr. Lori Yang, receives 2015 Amelia Earhart Innovator Award.

G&D awarded NIH STTR Phase I based on Lectenz® technology.

G&D's CEO, Dr. Kausar N. Samli, participates in panel discussion to highlight biotech growth in Georgia.

G&D participating in NIH Commercialization Assistance Program.

G&D participating in I-Corps South.

G&D's President, Dr. Robert J. Woods, receives 2014 Academic Entrepreneur of the Year Award.

G&D awarded NIH STTR Phase II and SBIR Phase II based on Lectenz® technology.

G&D awarded NIH SBIR Phase I based on GlycoSense™ technology.

Twitter

Follow G&D: